General
Preferred name
ABEDITEROL
Synonyms
LAS 100977 ()
ABEDITEROL NAPADISYLATE ()
LAS-100977 ()
LAS100977 ()
LAS100977 napadisylate ()
P&D ID
PD046769
CAS
915133-65-2
Tags
available
drug candidate
Drug indication
Chronic obstructive pulmonary disease
Drug Status
investigational
Max Phase
Phase 2
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Abediterol (AS100977) is an investigational long-acting beta(β)-agonist (LABA) , in development as a once-daily treatment for asthma and potentially COPD. Currently available LABAs approved for use by asthmatic patients include , and .
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Drugs
Concise Guide to Pharmacology 2023/24
DrugBank
DrugMAP
Guide to Pharmacology
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
460.22
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
4
Rotatable Bonds
13
Ring Count
3
Aromatic Ring Count
3
cLogP
4.23
TPSA
94.58
Fraction CSP3
0.4
Chiral centers
1.0
Largest ring
6.0
QED
0.29
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
